Rev Neurol
[Analysis of the family impact and needs of Dravet's syndrome in Spain].
Aledo-Serrano A, Mingorance A
Dravet's syndrome (DS) is an epileptic encephalopathy that starts in infancy and has an important impact on the lives of patients and their relatives. ...
Read More
Source: PubMed
CNS Drugs 2020 Jan 25
Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.
Stephen LJ, Brodie MJ
Common genetic generalised epilepsy syndromes encountered by clinicians include childhood and juvenile absence epilepsies, juvenile myoclonic epilepsy ...
Read More
Source: PubMed
Neurotherapeutics 2020 Jan 24
From Genetic Testing to Precision Medicine in Epilepsy.
Striano P, Minassian BA
Epilepsy includes a number of medical conditions with recurrent seizures as common denominator. The large number of different syndromes and seizure ty ...
Read More
Source: PubMed
Ann. Neurol. 2020 Jan 14
Scn8a antisense oligonucleotide is protective in mouse models of SCN8A Encephalopathy and Dravet Syndrome.
Lenk GM, Jafar-Nejad P, Hill SF, Huffman LD, Smolen CE, Wagnon JL, Petit H, Yu W, Ziobro J, Bhatia K, Parent J, Giger RJ, Rigo F, Meisler MH
SCN8A encephalopathy is a Developmental and Epileptic Encephalopathy (DEE) caused by de novo, gain-of-function mutations of sodium channel Nav 1.6 tha ...
Read More
Source: PubMed
Epileptic Disord 2020 Jan 14
Adverse effects of cannabinoids.
Anciones C, Gil-Nagel A
Cannabidiol is a cannabinoid-derived product that has recently been approved for the treatment of pharmacoresistant seizures in patients with epilepti ...
Read More
Source: PubMed
